Table 5 Comparison of adverse reactions between SBRT group and FRT group
Group (n) | Liver function damage | Myelosuppression | Nausea and vomiting | Fatigue and dizziness |
|---|---|---|---|---|
SBRT (36) | 0 | 13.89% (5/36) | 8.33% (3/36) | 13.89% (5/36) |
FRT (36) | 11.11% (4/36) | 25.00% (9/36) | 27.78% (10/36) | 52.78% (19/36) |
χ2 | 4.235 | 1.419 | 4.603 | 12.25 |
P | 0.039 | 0.234 | 0.032 | < 0.001 |